文献速递静脉血栓栓塞慢性静脉疾病

机械性 vs 流变性血栓清除术治疗髂股或髂腔深静脉血栓的中期临床结局

Midterm clinical outcomes of mechanical versus rheolytic thrombectomy for iliofemoral or iliocaval deep vein thrombosis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-02-05

这项多中心回顾性观察研究纳入122例髂股(78%)或髂腔(22%)深静脉血栓患者,比较机械性血栓清除术(MT,n=40)与流变性血栓清除术(RT,n=82)的中期结局。中位随访25个月,两组均保持高通畅率与免于血栓后综合征(PTS)率;MT组围术期溶栓使用率(38% vs 95%)和支架置入率(70% vs 98%)均更低,但腘静脉通路相关血栓发生率更高(13% vs 0%)。

要点

  • MT与RT均获得高中期通畅率和免于PTS率。
  • MT组围术期溶栓使用率和静脉支架置入率显著低于RT组。
  • MT组腘静脉通路血栓发生率为13%,RT组为0%,需进一步研究。

核心结论

  • MT与RT均与高通畅率和免于PTS率相关,MT可能减少溶栓需求和静脉支架置入。

研究设计与样本

  • 多中心、回顾性、观察性研究,纳入122例髂股(78%)或髂腔(22%)DVT患者,平均年龄48岁,57%为女性。
  • 所有患者接受早期血栓清除术,其中MT组40例,RT组82例,随访至少3个月,中位随访25个月(IQR 11-52个月)。

主要发现

  • MT组围术期溶栓使用率为38%,RT组为95%(P < .01)。
  • MT组支架置入率为70%,RT组为98%(P < .01)。
  • MT组5例(13%)发生腘静脉通路部位血栓,RT组无发生。
  • 1年一期通畅率:MT组80%(95%CI 67%-95%),RT组88%(95%CI 81%-96%);二期通畅率:MT组97%(95%CI 93%-100%),RT组97%(95%CI 94%-100%)。
  • 末次随访免于PTS率:MT组98%(95%CI 93%-100%),RT组94%(95%CI 87%-100%)。

临床怎么用

  • 对于髂股或髂腔DVT行早期血栓清除术,MT可减少溶栓药物使用和支架置入需求。
  • MT采用大口径通路时需关注腘静脉通路血栓风险。

局限性

  • 回顾性观察性设计,MT组与RT组样本量不均衡(40 vs 82)。
  • 随访时间中位数25个月,部分患者随访时间较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In patients with iliofemoral deep vein thrombosis (DVT), early thrombus removal reduces the risk of post-thrombotic syndrome (PTS). It remains uncertain if mechanical thrombectomy (MT) using the ClotTriever system may offer advantages as compared with rheolytic thrombectomy (RT) using the AngioJet ZelanteDVT. METHODS: In our multicenter, retrospective, observational study, we included 122 patients (mean age, 48 years; 57% women) with iliofemoral (78%) or iliocaval DVT (22%). All underwent early thrombus removal with either MT (n = 40) or RT (n = 82) and had a minimum of 3 months of follow-up. Periprocedural outcomes included periprocedural thrombolytic use, access complications, and stent placement rate. Clinical outcomes included stent patency rate and freedom from PTS. RESULTS: The median follow-up was 25 months (interquartile range, 11-52 months). Compared with RT, MT was associated with lower periprocedural thrombolytic use (38% vs 95%; P < .01) and a lower rate of stent placement (70% vs 98%; P < .01). Postprocedural access site thrombosis of the popliteal vein occurred in 5 MT patients (13%) and in none of the RT patients. At 1 year, primary and secondary patency rates were 80% (95% confidence interval [CI], 67%-95%) and 97% (95% CI, 93%-100%) in the MT group, and 88% (95% CI, 81%-96%) and 97% (95% CI, 94%-100%) in the RT group, respectively. Freedom from PTS at latest follow-up was observed in 98% of the MT group (95% CI, 93%-100%) and 94% of RT patients (95% CI, 87%-100%). CONCLUSIONS: Both MT and RT were associated with high patency rates and freedom from PTS. MT may decrease the need for thrombolysis and venous stent placement. Popliteal vein thrombosis from large-bore access in MT patients requires further investigation.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Forgo G, Cardi S, Fumagalli R, et al. Midterm clinical outcomes of mechanical versus rheolytic thrombectomy for iliofemoral or iliocaval deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41654121. doi:10.1016/j.jvsv.2026.102457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。